InsiderFlow

NXTC

NextCure, Inc.$6.84+0.44 (+6.88%)
Prev Close$6.40·MCap$24.7M·P/E—·Vol29.0K·Yield—
▲

Buys (12M)

5

$1.75M

▼

Sells (12M)

1

$184.8K

◆

Net Activity

Net Buyer

$1.57M

●

Active Insiders

2

last 12 mo

Over the past 12 months, insider activity at NextCure, Inc. (NXTC) has been dominated by buying, with 5 insider purchases totaling $1.75M and 1 insider sale totaling $184.8K. The most recent insider transaction was by ADAR1 Capital Management, LLC (10 percent owner), who purchased $62.9K worth of shares on Nov 13, 2026. NextCure, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $24.7M.

NXTC Insider Trading Activity

DateInsiderTypeValue
Nov 13, 2026 ADAR1 Capital Management, LLCBuy$62.9K
Nov 9, 2026 ADAR1 Capital Management, LLCBuy$23.9K
Oct 27, 2026 ADAR1 Capital Management, LLCBuy$53.7K
Aug 12, 2026 Simcere Zaiming, Inc.Sell$184.8K0.8% OS
Aug 3, 2026 ADAR1 Capital Management, LLCBuy$1.52M8.6% OS
Jul 29, 2026 ADAR1 Capital Management, LLCBuy$87.7K

NXTC Insider Buying Activity

The following table shows recent insider purchases of NextCure, Inc. (NXTC) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Nov 13, 2026 ADAR1 Capital Management, LLCBuy$62.9K
Nov 9, 2026 ADAR1 Capital Management, LLCBuy$23.9K
Oct 27, 2026 ADAR1 Capital Management, LLCBuy$53.7K
Aug 3, 2026 ADAR1 Capital Management, LLCBuy$1.52M8.6% OS
Jul 29, 2026 ADAR1 Capital Management, LLCBuy$87.7K

NXTC Insider Selling Activity

The following table shows recent insider sales of NextCure, Inc. (NXTC) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Aug 12, 2026 Simcere Zaiming, Inc.Sell$184.8K0.8% OS

NXTC Insiders

ADAR1 Capital Management, LLC

10 percent owner

Bought $1.75M
5 tradesLast: Nov 13, 2026
Simcere Zaiming, Inc.

other: Former 10% Owner

Sold $184.8K
1 tradesLast: Aug 12, 2026